Does ECULIZUMAB Cause Central venous catheterisation? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Central venous catheterisation have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.2% of all adverse event reports for ECULIZUMAB.
105
Reports of Central venous catheterisation with ECULIZUMAB
0.2%
of all ECULIZUMAB reports
3
Deaths
27
Hospitalizations
How Dangerous Is Central venous catheterisation From ECULIZUMAB?
Of the 105 reports, 3 (2.9%) resulted in death, 27 (25.7%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
GLYCINE\MANNITOL\SODIUM (56)
Which ECULIZUMAB Alternatives Have Lower Central venous catheterisation Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB